| Literature DB >> 35531168 |
Heba Badr1, Eman AbdelMenamm Shosha2, Heba Roshdy1, Ahmed Abd El-Halem Mohammed1, Noha Saad1, Salama Mostafa Aboelenin3, Mohamed Mohamed Soliman4, Amira M El-Tahan5, Mohamed T El-Saadony6, Nahed Yehia1.
Abstract
Pigeon's flocks have shown several neurological symptoms including circling, torticollis, tremors, paralysis, which caused suspicion for viral or bacterial natural infections. Pigeon paramyxovirus type-1 (PPMV-1) is a notifiable disease-causing high morbidity and mortality with severe nervous symptoms. Clinical represented tissue specimens were collected from 50 infected pigeon flocks in eight governorates. All samples were examined bacteriologically (isolation, identification and serotyping) for E. coli, Salmonella spp., S. aureus and pseudomonas aeruginosa. Antimicrobial susceptibility test (AST) was accomplished for all isolates using a disk-diffusion test. For viral identification, RT-PCR specific oligonucleotide primers were used for distinguishing of Avian influenza virus, PPMV-1 and PPMV-3. Neurological manifestations were observed in pigeon's flocks mainly in winter and autumn. The mortality rate in eight governorates was about 50% in 10 flocks and other houses mortality rate was ranged from 10 to 20%. Post mortem examination have shown hemorrhagic enteritis, soft and friable brain tissues and/or hemorrhages. The percentage of isolated bacteria E. coli, Salmonella spp., S. aureus and Pseudomonas aeruginosa were 75%, 75%, 50% and 18.75%; respectively. The antibiotic resistance pattern for bacterial isolates showed resist to ampicillin, amoxicillin- clavulinic acid, teteracyclin, ceftriaxone, doxycycline, sulfamethoxazole-trimethoprim and ceftazidine with different result for each type of bacteria, while Salmonella spp., isolates showed only a highly intermediate result for ciprofloxacin. Eight samples are positive with 16% to PPMV-1. Also, sample No.5,6,9 was co-infected with different types of bacterial isolates in addition to NDV. In conclusion, we reported several neurological symptoms in pigeon's flocks mainly of bacterial infections (E. coli, Salmonella spp., S. aureus and Pseudomonas aeruginosa).Entities:
Keywords: Avian influenza virus; Escherichia coli; Nervous signs; Newcastle disease virus; Pigeon bacterial and viral diseases; Salmonella species
Year: 2022 PMID: 35531168 PMCID: PMC9073067 DOI: 10.1016/j.sjbs.2022.01.023
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.052
History of samples collected from pigeon flocks.
| Giza | Domestic pigeons | 10 |
| Cairo | Foreign pigeon, domestic pigeon | 8 |
| El-Fayom | Domestic pigeons | 5 |
| El-Dakahalia | Domestic pigeons, foreign pigeon | 6 |
| El-Gharbia | Domestic pigeons, foreign pigeon | 7 |
| El Menofia | Domestic pigeons, foreign pigeon | 6 |
| El-Behera | Domestic pigeons | 4 |
| EL Kalubia | Domestic pigeons | 4 |
Fig. 1Pigeon populations suffered from severe nervous manifestation as neck twisting, and leg paresis or paralysis.
Fig. 2PM lesions of pigeon flocks (4-week-old pigeons). A and B: Congested brains. C: severe hemorrhagic enteritis.
Incidence of bacterial species from pigeon samples suffered from several nervous manifestations.
| Samples | Positive bacterial isolates (%) | ||||
|---|---|---|---|---|---|
| No. of | Examined | ||||
| Diseased (24 cases) | Organs | 12 | 18 | 9 | 6 |
| Brain | 21 | 18 | 9 | 6 | |
| Cecum | 15 | – | – | – | |
| Total positive diseased cases | 21 (87.5) | 18 (75) | 9 (37.5) | 6 (25) | |
| Dead (24 cases) | Brain | 15 | 18 | 15 | 3 |
| Bone marrow | 15 | 18 | 15 | 0 | |
| Total positive dead cases | 15 (62.5) | 18 (75) | 15 (62.5) | 3 (12.5) | |
| Total positive | 36 (75) | 36 (75) | 24 (50) | 9 (18.75) | |
Organs (liver, heart, spleen, lung).
Antimicrobial susceptibility pattern of the isolated Salmonella and E. coli from infected pigeons.
| Antimicrobial agent | ||||||
|---|---|---|---|---|---|---|
| Resistant | Intermediate | Sensitive | Resistant | Intermediate | Sensitive | |
| Amoxicillin-clavulinic acid (AMC30) | 36 (100%) | 0 | 0 | 36 (100%) | 0 | 0 |
| Ampicillin (AMP10) | 36 (100%) | 0 | 0 | 36 (100%) | 0 | 0 |
| Aztreonam (AT30) | 12 (33.3%) | 0 | 24 (66.7%) | 0 | 0 | 36 (100%) |
| Cefepime (CPM30) | 15 (41.7%) | 21 (58.3%) | 0 | 3 (8.33%) | 27 (75%) | 6 (16.7%) |
| Ceftazidime (CAZ30) | 21 (58.3%) | 15 (41.7%) | 0 | 0 | 24 (66.7%) | 12 (33.3%) |
| Ceftriaxone (CTR30) | 18 (50%) | 9 (25%) | 9 (25%) | 0 | 0 | 36 (100%) |
| Ciprofloxacin (CIP5) | 3 (8.3%) | 33 (91.7%) | 0 | 0 | 0 | 36 (100%) |
| Colistin sulphate (CL10) | 6 (16.7%) | 0 | 30 (83.3%) | 0 | 0 | 36 (100%) |
| Doxycycline (DO30) | 9 (25%) | 0 | 27 (75%) | 33 (91.7%) | 3 (8.3%) | 0 |
| Fosfomycin (FO200), | 9 (25%) | 0 | 27 (75%) | 0 | 0 | 36 (100%) |
| Gentamycin (GEN10) | 6 (16.7%) | 0 | 30 (83.3%) | 6 (16.7%) | 0 | 30 (83.3%) |
| Norfloxacin (NX10) | 3 (8.3%) | 6 (16.7%) | 27 (75%) | 0 | 0 | 36 (100%) |
| Streptomycin (S10) | 9 (25%) | 15 (41.7%) | 12 (33.3%) | 12 (33.3%) | 3 (8.3%) | 21 (58.3%) |
| Sulfamethoxazole-trimethoprim (SXT25) | 15 (41.7%) | 0 | 21 (58.3%) | 30 (83.3%) | 0 | 6 (16.7%) |
| Tetracycline (TE10) | 9 (25%) | 0 | 27 (75%) | 36 (100%) | 0 | 0 |
Percentage calculated by dividing the result to total number of isolates.
Antimicrobial susceptibility pattern of the isolated S. aureus and Pseudomonas aerginousa from infected pigeons.
| Antimicrobial agent | ||||||
|---|---|---|---|---|---|---|
| Resistant | Intermediate | Sensitive | Resistant | Intermediate | Sensitive | |
| Amoxicillin-clavulinic acid (AMC30) | 15 (62.5%) | 0 | 9 (37.5%) | 9 (100%) | 0 | 0 |
| Ampicillin (AMP10) | 24 (100%) | 0 | 0 | 9 (100%) | 0 | 0 |
| Aztreonam (AT30) | 24 (100%) | 0 | 0 | 0 | 3 (33.3%) | 6 (66.7%) |
| Cefepime (CPM30) | 12 (50%) | 12 (50%) | 0 | 3 (33.3%) | 3 (33.3%) | 3 (33.3%) |
| Ceftazidime (CAZ30) | 24 (100%) | 0 | 0 | 0 | 3 (33.3%) | 6 (66.7%) |
| Ceftriaxone (CTR30) | 3 (12.5%) | 12 (50%) | 9 (37.5%) | 9 (100%) | 0 | 0 |
| Ciprofloxacin (CIP5) | 3 (12.5%) | 3 (12.5%) | 18 (75%) | 0 | 6 (66.7%) | 3 (33.3%) |
| Colistin sulphate (CL10) | 15 (62.5%) | 0 | 9 (37.5%) | 6 (66.7%) | 0 | 3 (33.3%) |
| Doxycycline (DO30) | 3 (12.5%) | 3 (12.5%) | 18 (75%) | 9 (100%) | 0 | 0 |
| Fosfomycin (FO200), | 0 | 0 | 24 (100%) | 3 (33.3%) | 6 (66.7%) | 0 |
| Gentamycin (GEN10) | 3 (12.5%) | 3(12.5%) | 18 (75%) | 0 | 0 | 9 (100%) |
| Norfloxacin (NX10) | 0 | 3 (12.5%) | 21 (87.5%) | 0 | 0 | 9 (100%) |
| Streptomycin (S10) | 3 (12.5%) | 3 (12.5%) | 18 (75%) | 6 (66.7%) | 0 | 3 (33.3%) |
| Sulfamethoxazole-trimethoprim (SXT25) | 9 (37.5%) | 0 | 15 (62.5%) | 9 (100%) | 0 | 0 |
| Tetracycline (TE10) | 12 (50%) | 0 | 12 (50%) | 9 (100%) | 0 | 0 |
Percentage calculated by dividing the result to total number of isolates.
Fig. 3aAntimicrobial resistance pattern of the different bacterial isolates from infected pigeons.
Fig. 3bAntimicrobial resistance pattern of the different bacterial isolates from infected pigeons.
Fig. 4Viral and bacterial etiology of neurological manifestations in pigeon populations according to season.
Fig. 5Co-infection findings of viral and bacterial aetiology from tissue samples of pigeons.